Funding Opportunity RFA-ES-22-008 from the NIH Guide for Grants and Contracts. The objective of this funding opportunity announcement (FOA) is to solicit applications that propose to better understand the biological basis by which environmental exposures alter brain and behavioral functioning to increase risk for psychiatric disorders with onset in late-childhood, adolescence, or early adulthood. Since basic and pre-clinical research is critical for the study of neurobiological mechanisms that drive complex behaviors including mental illness, the focus of this FOA is to encourage a range of mechanistic approaches, from in vitro systems to whole organism models, to examine the link between environmental chemicals and possible contribution to the pathogenesis of psychiatric abnormalities. Investigations that further advance our understanding of the joint contribution of genes and environment in the risk for psychiatric disorders are also welcomed. It is anticipated that knowledge gained from the research supported by this FOA will inform the development of improved intervention, prevention and/or therapeutic strategies. This FOA will use the NIH Research Project Grant (R01) award mechanism and runs in parallel with the companion FOA, RFA-ES-22-009, which encourages applications under the R21 mechanism.

Funding Opportunity RFA-ES-22-009 from the NIH Guide for Grants and Contracts. The objective of this funding opportunity announcement (FOA) is to solicit applications that propose to better understand the biological basis by which environmental exposures alter brain and behavioral functioning to increase risk for psychiatric disorders with onset in late-childhood, adolescence, or early adulthood. The R21 grant mechanism is intended to encourage exploratory and developmental research projects that are high-risk and/or use novel approaches with potential for significant impact. Investigations that further advance our understanding of psychiatric conditions where there is less evidence of an environmental exposure link are of particular interest. Since basic and pre-clinical research is critical for the study of neurobiological mechanisms that drive complex behaviors including mental illness, the focus of this FOA is to encourage a range of mechanistic approaches, from in vitro systems to whole organism models, to examine the link between environmental chemicals and possible contribution to the pathogenesis of psychiatric abnormalities. Investigations that further advance our understanding of the joint contribution of genes and environment in the risk for psychiatric disorders are also welcomed. It is anticipated that knowledge gained from the research supported by this FOA will inform the development of improved intervention, prevention and/or therapeutic strategies. This FOA will use the NIH Exploratory/Developmental Research Grant (R21) award mechanism and runs in parallel with another FOA, RFA-ES-22-008, which encourages applications under the R01 mechanism.

Notice NOT-HS-22-024 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-CA-22-052 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), NCI, NIDA, and NCCIH invite Cooperative Agreement (U01) applications that propose prospective research studies to assess the benefits and harms of cannabis and cannabinoid use among adult cancer patients during active treatment. NCI, NIDA, and NCCIH are seeking well-designed prospective cohort studies of cancer patients with solid or hematologic tumors currently receiving treatment. Studies are expected to compare cancer patients who use cannabis/cannabinoids with cancer patients that do not use cannabis and/or cannabinoids. Research studies including diverse populations by age, sex, race/ethnicity, tumor types, and/or geography and propose population-based recruitment strategies using cancer registries are strongly encouraged. This FOA is published in parallel with RFA-CA-22-053 "Coordinating Center for Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U24 Clinical Trial Not Allowed). New prospective studies and the coordinating center funded under these FOAs will work together with NIH program staff.

Notice NOT-HS-22-025 from the NIH Guide for Grants and Contracts

Notice NOT-NS-23-028 from the NIH Guide for Grants and Contracts

Notice NOT-OD-22-224 from the NIH Guide for Grants and Contracts

Notice NOT-GM-22-046 from the NIH Guide for Grants and Contracts

Notice NOT-AT-22-033 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-004 from the NIH Guide for Grants and Contracts

Notice NOT-OD-22-191 from the NIH Guide for Grants and Contracts

Competitive Salary: F. Hoffmann-La Roche AG: The PositionThis position may be based out of Santa Clara, California, USA, with remote work locations possible in The United States.Impact Healthcare Santa Clara, California (US)

Notice NOT-AI-22-065 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-001 from the NIH Guide for Grants and Contracts

Notice NOT-DA-23-009 from the NIH Guide for Grants and Contracts

Interact with science teams and users to understand requirements and identify improvements to the software. Process, clean and verify the integrity of data used…
From Genus Plc - Thu, 29 Sep 2022 02:14:52 GMT - View all DeForest, WI jobs

Competitive Salary: F. Hoffmann-La Roche AG: The PositionWe are seeking a talented and highly motivated Principal Bioinformatics Scientist to support the development of Roche Diagnostics Molecula United States (US)

Competitive Salary: F. Hoffmann-La Roche AG: The PositionRoche Sequencing Solutions (RSS), a business within Roche Diagnostics, focused on developing a disruptive Next-Generation Sequencing (NGS) United States (US)

Competitive Salary: F. Hoffmann-La Roche AG: The PositionImpact Healthcare Roche is dedicated to advancing personalized healthcare by creating diagnostics and treatments tailored to individual ge San Jose, California (US)

Master’s degree in scientific related field, such as physics, engineering, biology, bioinformatics, statistics, computer science or related. $70,000 - $90,000 a year
From University of Wyoming - Wed, 28 Sep 2022 20:14:26 GMT - View all Laramie, WY jobs